Clinical Trials
- Liver
A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis (NATiV3)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular, Kidney & Urinary Tract, Genetics
Genetic Determinants of Aneurysms in Autosomal Dominant Polycystic Kidney Disease
- Ages18 years and older
- GenderBoth
- Liver, Genetics
Genetic Studies of Polycystic Livers
- Ages18 years and older
- GenderBoth
- Kidney & Urinary Tract
Treating Kidney Disease in Patients with APOL1
- Ages18 years - 60 years
- GenderBoth